We are live on
!
Find out more
SNNA
Sienna Biopharmaceuticals, Inc.
SNNA
SNNA
Delisted
SNNA was delisted on the 16th of December, 2019.
23 hedge funds and large institutions have $1.08M invested in Sienna Biopharmaceuticals, Inc. in 2019 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 4 increasing their positions, 13 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
52% less funds holding
Funds holding: 48 → 23 (-25)
69% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 13
91% less capital invested
Capital invested by funds: $12.3M → $1.08M (-$11.2M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 25
Holders
23
Holders Change
-25
Holders Change %
-52.08%
% of All Funds
0.5%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
4
Reduced
13
Closed
25
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
+$29.3K |
| 2 |
Goldman Sachs
New York
|
+$4.14K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$229 |
| 4 |
JP Morgan Chase
New York
|
+$15 |
